News and Views
Nature Medicine 15, 732 - 733 (2009)
doi:10.1038/nm0709-732
Targeting lymphotoxin depletes pathogenic T cells
Anna M. Hansen1 & Rachel R. Caspi1
- Anna M. Hansen and Rachel R. Caspi are in the Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, Maryland, USA.
Correspondence to: Rachel R. Caspi1 e-mail: rcaspi@helix.nih.gov
Abstract
A monoclonal antibody directed against lymphotoxin-
(LT-) expressed by pathogenic T cells can prompt the clearance of these cells from the body (pages 766–773). The findings bring us one step closer to targeting only the cell populations that cause harm in autoimmune diseases while leaving beneficial arms of the immune system largely intact.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Diagnostic Ionizing Radiation Exposure in a Population-Based Sample of Children With Inflammatory Bowel DiseasesThe American Journal of Gastroenterology Article Response
Targeted depletion of lymphotoxin-α?expressing T H 1 and T H 17 cells inhibits autoimmune diseaseNature Medicine Article (01 Jul 2009)
